GAMMA Investing »

Kalvista Pharmaceuticals shares owned by GAMMA Investing

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-03-31 $190 16 11.88
2023-12-31 $252 16 15.75

More positions owned by GAMMA Investing

Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Home Depot Common Stock (HD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Tang Capital Management
Vanguard Group
Boxer Capital
Caption Management
Citadel Advisors
Dimensional Fund Advisors
DAFNA Capital Management
Goldman Sachs Group
Rosalind Advisors
Citigroup
Two Sigma Advisers
Two Sigma Investments
Opaleye Management

View all funds holding Kalvista Pharmaceuticals